REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT07594106 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-25 → 2026-07-20 3. completion date: 2030-09-20 → 2030-10-27 4. primary completion date: 2030-09-20 → 2030-10-27
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical